News

OmniGuide Surgical Announces Commercial Launch of VELOCITY™ High Performance CO2 Laser Fiber

Lexington, MA – March 15, 2017 – OmniGuide Holdings, Inc., the parent company of OmniGuide Surgical announced today the full commercial release of its VELOCITY™ High Performance Fiber.  VELOCITY is the latest addition to OmniGuide’s advanced surgical energy platform and is designed to provide precision cutting with increased speed and performance while maintaining OmniGuide’s commitment to patient safety.

Unlike competitive fibers, OmniGuide’s enhanced safety fiber technology is infused with multiple mirrors as well as a protective outer layer which prevents laser energy leakage. With VELOCITY, the fibers have been developed for higher performance by increasing the mirror content to twelve distinct layers, which serve to increase wattage output and ultimately the cutting speed.  With cutting speed now equivalent to monopolar electrosurgery1, surgeons can reduce procedure time while maintaining  micron-level thermal spread and the tissue preservation benefits associated with CO2 energy.

“While CO2 has been at the forefront of precision cutting energy for 50 plus years, the precision has often been thought to come at the expense of speed” said Dr. Barry Wenig, an Otolaryngologist with the University of Illinois College of Medicine. “With VELOCITY, I am able to improve cautery in complicated cases while reducing the likelihood of post-operative complications by sparing healthy tissue.”

Another design improvement of the VELOCITY™ High Performance Fiber is that the hollow inner-core has been expanded to enable the newly increased energy transmission to be sustainable throughout the surgical case.  This specific design modification preserves the integrity of the higher speed CO2 laser transmission, making it applicable to a wider variety of open, laparoscopic and robotic procedures across multiple surgical specialties.

“We are dedicated to providing surgeons with the most precise energy tools to treat patients in a safe, reliable manner regardless of the surgical application. The VELOCITY™ High Performance Fiber encompasses the best of both worlds – fast, reproducible cutting without the collateral thermal damage often seen as a result of electrosurgery” said OmniGuide Holdings Inc.’s CEO John Buhler.


 

About OmniGuide Holdings, Inc.  

OmniGuide Holdings is a patient safety-focused medical technology innovator, providing a portfolio of advanced energy surgical tools to benefit clinicians and their patients.  The company’s technologies deliver energy in a precise and electrically silent manner, resulting in the preservation of healthy tissue.

OmniGuide Surgical, a leader in flexible fiber CO2 laser technology, offers a range of products designed to enhance surgical accuracy, access and control for minimally invasive surgery, laparoscopy and robotic-assisted surgery.

Domain Surgical, by OmniGuide, provides a patented ferromagnetic technology designed to provide safety and predictability in select surgical procedures that require cutting, coagulating and sealing tissue.

 

Contacts

John Barnhill
VP of Marketing & Business Development
+1-949-500-5082
jbarnhill@omni-guide.com

1. Data on file at OmniGuide Surgical

 

Posted in: Company News, Press Releases

Leave a Comment (0) →

OmniGuide Holdings, Inc. Hires John Markovich as CFO, Ajay Bhave as VP Operations and John Barnhill as VP Marketing & Business Development

Lexington, MA – November 10, 2016 – OmniGuide Holdings, Inc., the parent company of OmniGuide Surgical, Inc. and Domain Surgical, Inc., announced today the appointment of John Markovich as CFO.  The company also named Ajay Bhave as VP of Operations and John Barnhill as VP of Marketing / Business Development.  The addition of Markovich, Bhave and Barnhill follows the recent appointment of new President and CEO John T. Buhler and the company’s recently announced merger with Domain Surgical, which complements OmniGuide Surgical’s leadership in flexible fiber CO2 laser surgery by offering electrically silent ferromagnetic technology that has been clinically proven to precisely cut, coagulate and seal tissue.  The recent leadership additions continue OmniGuide Holdings’ commitment to enhancing OmniGuide Surgical’s growing CO2 laser business while commercially accelerating the Domain Surgical product line.

John Markovich Image

John Markovich

Reporting to Buhler, Markovich as CFO will be oversee the company’s overall financial operations.  Markovich has over 25 years of diverse financial leadership experience, which includes directing multiple privately-held startups and several public companies, including a NYSE-listed Fortune 500 multi-national, in both the healthcare and technology industries.  Previously, Markovich held CFO positions with Veritone, Inc., NanoH20, Inc., EMCORE Corporation and Orqis Medical, Inc.

“John’s extensive experience directing all financial and business management activities for companies of varying sizes, as well as his involvement with numerous successful M&A and IPO transactions make him a valuable addition to our team,” said Buhler. “John’s financial acumen will help guide the company as we continue along our growth trajectory, focusing on new opportunities within the advanced energy space.”

Ajay Bhave Image

Ajay Bhave

Bhave, who as part of OmniGuide Holdings senior staff, will be responsible for the company’s Global Operations, including manufacturing and the integration of Domain Surgical.  Prior to joining OmniGuide Holdings, Inc., Bhave held the position of Corporate VP of Global Engineering with Natus Medical Inc., with responsibility for all aspects of new product development.   Prior to Natus, he held a number of senior management positions, including global supply chain and plant management, during his 21 years with General Electric Healthcare.

“Ajay’s 32 years of medical device manufacturing and engineering experience will help us enhance our operational capabilities, providing an analytic-based discipline that will ultimately accelerate our manufacturing operations while simultaneously maintaining OmniGuide’s high standard of quality,” said Buhler. “This is vital as we expand our core advanced energy portfolio to include Domain Surgical’s high-performance ferromagnetic technology”.

John Barnhill Image

John Barnhill

Barnhill will be responsible for global marketing efforts and business development strategy. Previously, Barnhill held a similar position with RF Surgical, Inc., an early-stage medical technology company that was recently acquired by Medtronic.  Prior to that, Barnhill was with Edwards Lifesciences where he held several global marketing and medical education positions within both the Heart Valve Therapy and Critical Care franchises.  Barnhill also held a marketing leadership position with SenoRx, where he grew the company’s breast cancer therapy portfolio, contributing to the successful exit of the company.  He will also report to Buhler.

“By adding John to our team, the company has demonstrated its commitment to building awareness around our advanced energy applications as well as implementing marketing strategies to support our growth aspirations,” said Buhler. “John’s market development expertise will help us educate a broader customer base around the performance and patient safety benefits associated with our product portfolio.”


About OmniGuide Holdings, Inc.

OmniGuide Holdings is a patient safety-focused medical technology innovator, providing a portfolio of advanced energy surgical tools to benefit clinicians and their patients.  The company’s technologies deliver energy in a precise and electrically silent manner, resulting in the preservation of healthy tissue.

OmniGuide Surgical, a leader in flexible fiber C02 laser technology, offers a range of products designed to enhance surgical accuracy, access and control for minimally invasive surgery, laparoscopy and robotic-assisted surgery.

Domain Surgical, by OmniGuide, provides a patented ferromagnetic technology designed to provide safety and predictability in select surgical procedures that require cutting, coagulating and sealing tissue.


Contacts

John Barnhill
VP of Marketing & Business Development
+1-949-500-5082

jbarnhill@omni-guide.com

Posted in: Company News, In the News, Press Releases

Leave a Comment (0) →

OmniGuide Holdings Completes Merger of OmniGuide & Domain Surgical

omniguide-domain-mergerLexington, MA – August 10, 2016 – OmniGuide Holdings, Inc., the parent company of OmniGuide, Inc., a leader in flexible fiber CO2 laser surgery, announced today that it has signed an agreement to merge with Domain Surgical Inc., to enhance its advanced energy surgical portfolio.

The merger with Domain Surgical, Inc., Salt Lake City, UT broadens the ability to bring safe and precise surgical technologies to more surgeons and patients.  Domain Surgical is the maker of the FMX Ferromagnetic Surgical System, a surgical platform that uses ferromagnetic technology to precisely and safely cut, coagulate and seal tissue; with minimal injury to surrounding tissue as compared to other surgical technologies.

Despite advances in technology, surgical interventions can cause undesired collateral damage to healthy tissue, which can lead to post-operative pain, prolonged patient recovery and complications.  Domain Surgical’s patented ferromagnetic technology is based on the principle of ferromagnetic heating.  Simply described, heat is produced when a material having magnetic “domains” is exposed to an alternating magnetic field. The result is a surgical system that provides consistent cutting and hemostasis, with much less thermal injury than traditional electrosurgery, without passing potentially dangerous electrical current through the patient.

OmniGuide’s combined technologies now deliver a variety of surgical applications, to ENT and GYN surgeons, ranging from precision cutting and ablation, to quick hemostatic dissection, to reliable vessel sealing; all with optimized precision and safety, without passing electrical current through the patient.

In conjunction with the merger, John T. Buhler, has been named President and CEO of OmniGuide Holdings.  Mr. Buhler has extensive experience in the technology, life-sciences and healthcare fields with a career spanning 30+ years. He has been the CEO/COO of three public and two private companies, completed numerous rounds of financing, done ~$1 billion in mergers and acquisitions, and most recently merged RF Surgical Systems, Inc. with Medtronic. He has successfully completed four turnarounds, with each entity becoming a high growth/profitable business in its discipline. Mr. Buhler has an impressive history generating new revenue streams, building business, and increasing market share for multi-million and multi-billion dollar international high-technology corporations. His businesses have demonstrated the ability to penetrate new markets and strengthen competitive positioning, design and direct high-impact strategic plans, define visions and transform concepts into lucrative workable realities.

“Both OmniGuide and Domain Surgical technologies are known for extreme precision and for minimizing unintended collateral damage to healthy tissue during complex surgical procedures. Further, both technologies are designed to increase patient safety and improve clinical outcomes,” said Mr. Buhler. “Merging the companies provides an expanded advanced energy product portfolio that delivers precise cutting, ablation, dissection, and vessel sealing capabilities across numerous sub-specialties. I am excited to be a part of this dynamic team as we grow the company moving forward.”

About OmniGuide Surgical

OmniGuide Surgical is an advanced energy company focused on surgeons and patients.  OmniGuide’s technologies deliver energy in a safe, reliable manner resulting in the preservation of healthy tissue.


Contacts

Jim Roveda
Director of Marketing – OmniGuide Surgical
+1-617-902-9200

Ryan Jeppesen
Marketing Manager – Domain Surgical
+1-801-924-4967

Posted in: Company News, Press Releases

Leave a Comment (0) →

Nimble Laser Devices for Minimally Invasive Gynecologic Surgery

Here is an except from a recent article in Contemporary OB-GYN. Please click here to read this article in it’s entirety.

“In our clinical practices, we use the CO2 laser delivered by flexible fiber in myomectomy, lysis of adhesions, and treatment of endometriosis. We find that it functions extremely well in all these situations, thanks to its specific maneuverability, functionality, and safety profiles, especially in conjunction with the minimal depth of penetration of thermal damage. This provides increased safety while working near critical structures such s bowel, bladder, ureters, and blood vessels.”

Source: Robinson AM, Fishman AJ, Bendok BR, Richter CP. Functional and physical outcomes following use of a flexible CO2 laser fiber and bipolar electrocautery in close proximity to the rat sciatic nerve with correlation to an in vitro thermal profile model. Biomed Res Int. 2015;280254.

 

Posted in: Education, Endometriosis, Gynecology, Infertility, Robotic-Assisted Surgery

Leave a Comment (0) →

TORS-L Eliminates Adjuvant Therapies In An Oropharyngeal Cancer Patient

With a diagnosis of stage 2 squamous cell carcinoma of the tonsil, Tony Lentola might have expected a treatment plan that included the traditional six weeks of radiation – and possibly chemotherapy.  Thanks to a referral to Ron Karni, MD, who routinely does surgery for oropharyngeal cancers using transoral robotic surgery with a CO2 laser (TORS-L), Lentola avoided the toxic treatments, the effects of which are particularly pronounced in head and neck cancer patients.

RK by-lineLentola is one among many patients at UTHealth and Memorial Hermann-Texas Medical Center to benefit from the coupling of the da Vinci robot to the flexible CO2 fiber, which can be used to precisely resect tumor margins.  Diagnosed in November 2013, the 64-year-old underwent surgery with TORS-L following a biopsy that confirmed the malignancy.  “We’ve found that combining transoral robotic surgery with a CO2 laser allows for greater precision, a better chance of cancer cure and elimination or de-intensification of adjuvant therapies in cases of early diagnosis,” says Dr. Karni, an assistant professor in the Department of Otorhinolaryngology-Head and Neck Surgery at UTHealth Medical School, who focuses his practice on head and neck oncologic surgery and diseases of the thyroid and parathyroid.  “The toxicity of these treatments in oropharyngeal cancer patients is well-documented, and many of the effects are lifelong. By avoiding them, we improve functional outcomes.”

To continue reading click here.

Posted in: Education, ENT, Head & Neck, In the News

Leave a Comment (0) →

Laser Safety Training Video for GYN (Surgeon Narrated)

Amelia Bailey, MD, Director of Minimally Invasive Surgery at Fertility Associates of Memphis, recently helped OmniGuide Surgical design a video overview for laser safety in the operating room. Dr. Bailey explains how “it is important to recognize that not all lasers are created the same” and details how CO2 laser can be ideal for surgery because it is highly absorbed in water and tissue so energy is halted near the surface. In addition to explaining the properties of different laser wave lengths, she also goes over proper safety protocols and best practices for using the OmniGuide CO2 laser system in the OR.


 

With over 100,000 surgeries completed, OmniGuide has pioneered and lead the way for flexible CO2 laser use in today’s operating room and is redefining the energy for minimally invasive surgery. For more information or to request a demo of our technology please contact OmniGuide Surgical here.

Posted in: Gynecology, Robotic-Assisted Surgery

Leave a Comment (0) →

Surgeon Narrates Video of Vocal Cord Dysplasia Case with ELEVATE ENT System

M. Boyd Gillespie, MD, an otolaryngologist-head and neck surgeon at the Medical University of South Carolina, recently had a Vocal Cord Dysplasia case with a 39-year-old male patient who had a history of early vocal cord cancer. Following radiation, he had persistent dysplastic tissue on the surfaces of his vocal cords that showed poor mobility on stroboscopic examination. As explained by Dr. Gillespie in the narrated surgical video below, “Given the large size of the dysplasia a simple biopsy may miss sites of cancer, therefore, in this case, we are using the laser fiber to perform a complete vocal cord stripping so that the entire surface of the vocal cord can be analyzed by the pathologist.”

The surgeon chose to perform the case using the ELEVATE™ ENT System, OmniGuide Surgical’s next-generation flexible CO2 laser fiber system designed specifically for head and neck and airway surgery. Of the minimally invasive technology Gillespie explains, “The Elevate tip allows palpation of the underlying vocal ligament while the laser fiber works in a bloodless plane to lift the dysplastic tissue off the vocal fold.”

With over 100,000 surgeries completed, OmniGuide has pioneered and lead the way for flexible CO2 laser use in today’s operating room and is redefining the energy for minimally invasive surgery. For more information or to request a demo on the ELEVATE ENT System please contact OmniGuide Surgical here.

Posted in: Elevate System, ENT, Head & Neck

Leave a Comment (0) →

Carbon Dioxide Laser is Newest Surgical Advancement for Endometriosis

Over the past few months, there have been several advancements in the field of surgical treatment for endometriosis including the carbon dioxide (CO2) laser that can be used with robotic and conventional laparoscopy and open surgery.

“This laser has come a long way from the laser surgery of the 1990s, said Kevin Stepp, MD, director of advanced surgical specialties for women at Carolinas HealthCare System. “The technology is very different and there is much less risk of inadvertent damage to surrounding tissues.” Read more…

Posted in: Gynecology, In the News, Infertility, Robotic-Assisted Surgery

Leave a Comment (0) →
Page 1 of 3 123